Beyond cosmetics — chronic migraines, excessive sweating, TMJ, and muscle spasticity.

Migraine Treatment Protocol

In 2010, the FDA approved Botox for the prevention of chronic migraines — defined as headaches occurring on 15 or more days per month, with at least 8 of those days meeting migraine criteria. The approval was based on two large phase 3 clinical trials (PREEMPT 1 and PREEMPT 2) demonstrating a significant reduction in headache days compared to placebo. The standard protocol, known as the PREEMPT protocol, involves 155–195 units of onabotulinumtoxinA delivered across 31–39 injection sites spanning the forehead, temples, back of the head, neck, and upper trapezius muscles — all within a single treatment session repeated every 12 weeks.

The mechanism is not fully understood, but current evidence suggests that Botox interrupts the peripheral sensitization cycle that drives chronic migraine by blocking the release of pain-signaling neuropeptides, including substance P and CGRP, from trigeminal sensory nerve terminals. Patients typically see meaningful reduction in headache frequency after the second or third treatment cycle — it is not an immediate effect. While neurologists and headache specialists typically manage chronic migraine Botox, patients at Auveau who experience significant jaw clenching or tension headaches often find that masseter and temporalis Botox provides relief by reducing the muscular tension that can trigger or compound headache episodes. Chrissy Gray Lim, PA-C will discuss whether your symptoms fall within a scope she can address or whether a neurologist referral is the more appropriate path.

Hyperhidrosis: FDA-Approved Sweat Reduction

Primary axillary hyperhidrosis — excessive sweating of the underarms not caused by heat or exertion — received FDA approval for Botox treatment in 2004. The condition affects an estimated 3% of the US population and is distinct from normal thermoregulatory sweating; it is driven by overactive signaling from the eccrine sweat glands, which are innervated by cholinergic sympathetic nerve fibers. Botox blocks acetylcholine release at these nerve terminals, effectively switching off the overactive glands in the treated area.

The treatment protocol involves intradermal injections of 50 units per axilla — delivered in a grid pattern across the entire vault of the underarm — using a fine 30-gauge needle. Most patients describe the sensation as minimal, particularly when the skin is pre-cooled. The anhidrotic effect typically begins within 2–4 weeks and lasts 4–6 months on average, with some patients reporting up to 12 months of relief. Off-label, the same principle applies to palmar hyperhidrosis (sweaty palms) and plantar hyperhidrosis (sweaty feet), though these areas require more units and have a higher discomfort profile due to the density of nerve endings. For patients who have struggled with antiperspirant failure, clothing damage, or social anxiety related to visible sweat, axillary Botox offers a clinically validated, highly effective solution. Reach out to discuss whether you are a candidate.

TMJ And Jaw Pain Relief

Temporomandibular joint (TMJ) disorders and bruxism (teeth grinding) share a common driver: hyperactivity of the masseters and temporalis muscles. While TMJ disorders encompass a broad spectrum of joint and muscular dysfunction, the muscular component — specifically overloaded masseter activity — responds well to Botox intervention. By reducing the contractile force of these muscles, Botox decreases the pressure load on the TMJ disc and surrounding structures, which in turn reduces pain, clicking, and inflammation in many patients.

The cosmetic benefit — jaw slimming through masseter reduction — occurs in parallel with the therapeutic benefit, making this one of the few aesthetic treatments with a genuine functional upside. Typical dosing is 20–30 units per masseter, with the injection placed in the muscle belly identified by having the patient clench. The relaxation effect develops over 4–6 weeks as the muscle adapts to reduced neural drive and begins to decrease in bulk. Most patients report noticeable improvement in jaw soreness and morning headaches within the first treatment cycle. Nightguards and dental appliances address the joint and dental surface protection but do not reduce muscle hyperactivity — Botox addresses what an appliance cannot. Chrissy will assess your bite, masseter size, and symptom history to determine whether Botox, a dental referral, or both are indicated.

Muscle Spasticity

Botox holds multiple FDA approvals for the treatment of limb spasticity in adults and children — upper limb spasticity (2010), lower limb spasticity in adults (2016), and upper limb spasticity in pediatric patients age 2 and older (2019). Spasticity is a velocity-dependent increase in muscle tone caused by damage to the upper motor neuron pathways, commonly from stroke, traumatic brain injury, cerebral palsy, or multiple sclerosis. It results in involuntary muscle co-contraction, resistance to passive movement, and often significant pain. Botox injected into spastic muscles blocks the hyperactive motor nerve signaling, reducing tone, improving range of motion, and facilitating physical therapy.

In the medical aesthetics context, the most relevant overlap is in patients who carry chronic neck and shoulder tension or torticollis — abnormal head posturing caused by involuntary cervical muscle contraction. Cervical dystonia is an FDA-approved indication (as BOTOX for cervical dystonia, 2000), and patients who present with significant neck tension or holding patterns often benefit from targeted muscle relaxation in the cervical and trapezius region. While spasticity management at a clinical neurology level is outside the scope of a medical spa, Chrissy Gray Lim, PA-C regularly addresses the functional-cosmetic overlap in neck and jawline treatment and will refer to the appropriate specialist when the clinical picture suggests a neurological or orthopedic cause underlying a patient's symptoms. The line between therapeutic and aesthetic Botox is often more permeable than patients expect — the same treatment that improves your jaw contour may also relieve your headaches.

Why Patients Choose Auveau

With a 5.0-star rating from 233 patient reviews on Google, Auveau has built its reputation on results that look natural and care that feels personal. Understanding Botox's full clinical picture — not just its cosmetic applications — allows Chrissy Gray Lim, PA-C to treat the whole patient, not just the visible concern. We are women-owned, LGBTQ+ friendly, and committed to honest clinical guidance whether your goals are aesthetic, functional, or both. Every consultation is complimentary — book yours today.